Qinghong Zhang
Shiyan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
A Phase III Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating Desidustat's Efficacy and Safety in Non-Dialysis Chronic Kidney Disease Patients with Anemia.
Journal: American journal of nephrology
Published: September 29, 2025
Endothelial cell-specific knockout of ATG5 ameliorates inflammation and renal fibrosis by regulating pyroptosis.
Journal: Inflammation research : official journal of the European Histamine Research Society ... [et al.]
Published: September 05, 2025
Randomized Double-Blind Trial of WS016 in Chinese Patients With Hyperkalemia.
Journal: Kidney international reports
Published: August 06, 2025
Lonicerin alleviates LPS-evoked inflammation and apoptosis in HK2 cells.
Journal: Allergologia et immunopathologia
Published: July 31, 2025
Glycolysis and NLRP3 inflammasome activation in diseases.
Journal: European journal of medical research
Published: May 28, 2025
Hyperkalemia burden and treatment patterns in Chinese patients on hemodialysis: final analysis of a prospective multicenter cohort study (PRECEDE-K).
Journal: Renal failure
Published: September 10, 2024
Hyperkalaemia prevalence and dialysis patterns in Chinese patients on haemodialysis: an interim analysis of a prospective cohort study (PRECEDE-K).
Journal: BMC nephrology
Published: January 31, 2023
Hyperkalaemia prevalence, recurrence and treatment in patients on haemodialysis in China: protocol for a prospective multicentre cohort study (PRECEDE-K).
Journal: BMJ open
Published: December 23, 2021
lncRNA MSC-AS1 activates Wnt/β-catenin signaling pathway to modulate cell proliferation and migration in kidney renal clear cell carcinoma via miR-3924/WNT5A.
Journal: Journal of cellular biochemistry
Published: June 21, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026